MedPath

Medico-economic Evaluation of Preoperative Cerebral Oximetry Monitoring During Carotid Endarterectomy

Phase 3
Terminated
Conditions
Internal Carotid Stenosis
Interventions
Other: cerebral oximetry monitoring using INVOS™ and hemodynamic optimisation
Other: standard cerebral monitoring and hemodynamic optimisation
Registration Number
NCT01415648
Lead Sponsor
Nantes University Hospital
Brief Summary

In France, in 2007, 17 000 patients underwent carotid endarterectomy. The risk of having an ipsilateral postoperative stroke after carotid endarterectomy remains at 1-1.5%. There is no consensus concerning the best cerebral monitoring and hemodynamic optimisation during carotid cross-clamping.

The objective of this prospective, multicentric, double-blinded and randomized study is to evaluate the interest of continuous cerebral oximetry monitoring by INVOS™ cerebral oximeter to direct the hemodynamic optimisation during carotid endarterectomy and reduce the new-onset of postoperative radiological (MRI) ischemic lesions. A cost/effectiveness analysis will be conducted to estimate the impact of this monitoring versus standard care on direct and indirect postoperative costs during 120 days.

A substudy will evaluate the effect of this monitoring on neurocognitive outcome and on a serum marker of brain injury, protein S-100B

Detailed Description

After consent, patients will be randomized in two groups: one group with continuous per operative cerebral oximetry monitoring associated with hemodynamic optimisation algorithm (excluding norepinephrine) if cerebral oximetry decrease more than 15% under the preoperative baseline; the second group is continuously monitored with cerebral oximeter but this latter is blinded to the medical team, the alarm switch off , and patients are managed with the standard care of the centre.

All patients have a preoperative and a postoperative diffusion cerebral MRI to detect new onset of cerebral ischemic lesion. The amount and the volume of cerebral ischemic lesions will be scored to compare groups.

Quality of life as well as direct (medical and nonmedical) and indirect costs were collected using questionnaires during the 120 postoperative days.

A substudy including 200 patients will be conducted to compare the two groups concerning postoperative protein S-100B level and a composite score of neurocognitive tests (measured pre- and postoperatively) The trial will be conducted according to GCP

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
879
Inclusion Criteria
  • Patients (male-female) over 18 y.o.
  • Presenting an internal carotid stenosis requiring surgery
  • Mini Mental State Examination >24 during preoperative examination
  • Informed written consent
Exclusion Criteria

Exclusion criteria:

  • Severe renal failure or requiring dialysis
  • Liver failure or cirrhosis (Child class ≥ B) or prothrombin activity<50%
  • Heart failure (NYHA ≥ III), left ventricular ejection fraction < 40%, acute coronary syndrome,
  • Associated surgery
  • Pregnancy
  • Contraindication to MRI
  • History of allergy to modified gelatine or starch
  • History of allergy to adhesive part of electrode

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
open NIRScerebral oximetry monitoring using INVOS™ and hemodynamic optimisationcontinuous per operative cerebral oximetry monitoring (using INVOS™ cerebral oximeter) associated with hemodynamic optimisation algorithm (excluding norepinephrine) if cerebral oximetry decrease more than 15% under the preoperative baseline
Blinded NIRSstandard cerebral monitoring and hemodynamic optimisationContinuously monitored with cerebral oximeter but this latter is blinded to the medical team, the alarm switch off , and patients are managed with the standard care of the centre
Primary Outcome Measures
NameTimeMethod
The number of new cerebral ischemic lesionsUp to 3 days post-operative

The number of new cerebral ischemic lesions observed on postoperative diffusion MRI

Secondary Outcome Measures
NameTimeMethod
Incremental cost-effectiveness ratio comparing the group monitored by cerebral oximeter and the standard care group4 months post-operative
Hospitalization length of stay4 months post-operative
Percentage of patient with Neurologic and neurocognitive postoperative disorders4 months post-operative

* Percentage of patient with Spatiotemporal disorientation

* Percentage of patient with aphasia

* Percentage of patient with Facial paralysis

* Percentage of patient with Limb sensory or motor deficit

* Percentage of patient with Seizure

* Percentage of patient with Balance disorder

Percentage of patient with Surgical events4 months post-operative

* Percentage of patient with surgical site infection

* Percentage of patient with haematoma evacuation

Postoperative quality of life (SF36, EQ5D tests)4 months post-operative

SF36 score for quality of life assessment :

* Physical quality score \[Time Frame: Through study completion, 4 month postoperatively\] Items from the SF36 (Short Form 36) survey

* Mental quality score \[Time Frame: Through study completion, 4 month postoperatively\] Items from the SF36 (Short Form 36) survey

EQ5D3L test for quality of life assessment :

* Quality of life evaluated by the EQ 5D 3L questionnaire \[Time Frame: 4 months postoperatively\]

* Quality of life, as evaluated by the use EQ 5D 3L auto-questionnaire

Percentage of patient with Cardiovascular postoperative disorders4 months post-operative

* Percentage of patient with myocardial infaction

* Percentage of patient with atrial fibrillation or atrial flutter

* Percentage of patient with acute left ventricle failure

* Percentage of patient with Uncontrolled high blood pressure

Incidence of death 4 month postoperatively4 months post-operative

Trial Locations

Locations (19)

Hospital de Marie Lannelongue Plessis Robinson

🇫🇷

Le Plessis Robinson, France

Nice University Hospital "Saint-Roch"

🇫🇷

Nice, France

Le Mans Hospital

🇫🇷

Le Mans, France

"Nouvelles Cliniques Nantaises"

🇫🇷

Nantes, France

"Groupe Hospitalier Saint-Joseph"

🇫🇷

Paris, France

"Hôpital Européen Georges Pompidou"

🇫🇷

Paris, France

Toulouse University Hospital

🇫🇷

Toulouse, France

Reims University Hospital "Robert Debré"

🇫🇷

Reims, France

Rennes University Hospital "Pontchaillou"

🇫🇷

Rennes, France

Strasbourg University Hospital

🇫🇷

Strasbourg, France

Dijon University Hospital "Le Bocage"

🇫🇷

Dijon, France

Besancon University Hospital "Hôpital Jean Minjoz"

🇫🇷

Besancon, France

Bordeaux University Hospital "Hôpital Pellegrin"

🇫🇷

Bordeaux, France

Bordeaux University Hospital "Haut Lévêque"

🇫🇷

Bordeaux, France

Brest University Hospital "La Cavale Blanche"

🇫🇷

Brest, France

Caen University Hospital "Côte de Nacre"

🇫🇷

Caen, France

Marseille University Hospital "Hôpital de la Timone"

🇫🇷

Marseille, France

Lyon University Hospital "Hôpital Edouard Herriot"

🇫🇷

Lyon, France

Nantes University Hospital

🇫🇷

Nantes, France

© Copyright 2025. All Rights Reserved by MedPath